A recent review found that patients using GLP-1 medications may be at increased risk for 19: Low protein intake Reduced intake of key micronutrients like vitamin D, iron, and calcium Declines in vitamin B12 and thiamine (B1) over time In some cases, this may contribute to: Fatigue or low energy Loss of lean muscle mass Longer-term nutrient deficiencies, if not addressed This is not a reason to avoid these medications, but it does highlight the importance of dietary quality and intentional nutrition support from a qualified professional while using them
10,33 With regard to the secondary outcome of HF hospitalisation, the results were neutral, with LEADER showing a non-significant relative risk reduction (RRR) of 13% with liraglutide compared with placebo and SUSTAIN-6 showing no significant difference between the semaglutide and placebo treatment groups
Biochemical determination of glutathione forms The concentration of total glutathione, its reduced (GSH) and oxidized form (GSSG), was determined in the extracts obtained after the disintegration process of yeast cells according to the manufacturers instructions (BioVision, Mountain View, CA, USA)
They can take your medical history and other factors into consideration and help you determine which GLP-1 may be the right fit for you